An isoenzyme-selective inhibitor of phosphodiesterase 4 and 1, KF19514, may be useful in the treatment of systemic anaphylaxis: An in vivo study in rabbits

Shock

Volumn 12, Issue 1, 1999, Pages 46-53

  Hasome, Naoki ^a   Mitsuhata, Hiromasa ^b   Saitoh, Jin ^a   Takeuchi, Haruhiko ^a   Shimizu, Reiju ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aminophylline; Cardiovascular; PDE 4 inhibitor; Pulmonary dynamics

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; BRONCHODILATING AGENT; ISOENZYME; KF 19514; NAPHTHYRIDINE DERIVATIVE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV;

ANAPHYLAXIS; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; HEMODYNAMICS; LUNG COMPLIANCE; METABOLISM; PATHOPHYSIOLOGY; RABBIT;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANAPHYLAXIS; ANIMALS; BRONCHODILATOR AGENTS; HEMODYNAMIC PROCESSES; ISOENZYMES; LUNG COMPLIANCE; NAPHTHYRIDINES; PHOSPHODIESTERASE I; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; RABBITS;

EID: 0033163488     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199907000-00007     Document Type: Article

References (33)

1. Feldman PL, Brackeen MF, Cowan DJ, Marron BE, Schoenen FJ, Stafford JA, Suh EM, Domanico PL, Rose D, Leesnitzer MA, Brawley ES, Strickland AB, Verghese MW, Connolly KM, Bateman-Fite R, Noel LS, Sekut L, Stimpson SA: Phosphodiesterase type IV inhibition. Structure-activity relationships of 1,3-disubstituted pyrrolidines. J Med Chem 38:1505-1510, 1995.
2. Torphy TJ, DeWolf WE, Jr., Green DW, Livi GP: Biochemical characteristics and cellular regulation of phosphodiesterase IV. Agents Actions Suppl 43:51-71, 1993.
3. Jones TR, McAuliffe M, McFarlane CS, Piechuta H, Macdonald D, Rodger IW: Effects of a selective phosphodiesterase IV inhibitor (CDP-840) in a leukotriene-dependent non-human primate model of allergic asthma. Can J Physiol Pharmacol 76:210-217, 1998.
4. Santing RE, Olymulder CG, Van der Molen K, Meurs H, Zaagsma J: Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur J Pharmacol 275:75-82, 1995.
5. Heaslip RJ, Lombarde LJ, Golankiewicz JM, Ilsemann BA, Evans DY, Sickels BD, Mudrick JK, Bagli J, Weichman BM: Phosphodiesterase-IV inhibition, respiratory muscle relaxation and bronchodilation by WAY-PDA-641. J Pharmacol Exp Ther 268:888-896, 1994.
6. 2-adrenoceptor agonists in asthma. Trends Pharmacol Sci 17:331-336, 1996.
7. Underwood DC, Osborn RR, Novak LB, Matthews JK, Newsholme SJ, Undem BJ, Hand JM, Torphy TJ: Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther 266:306-313, 1993.
8. Schade FU, Schudt C: The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages. Eur J Pharmacol 230:9-14, 1993.
9. Molnar-Kimber K, Yonno L, Heaslip R, Weichman B: Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors. Agents Actions 39 Spec No: C77-79, 1993.
10. Harbinson PL, MacLeod D, Hawksworth R, O'Toole S, Sullivan PJ, Heath P, Kilfeather S, Page CP, Costello J, Holgate ST, Lee TH: The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects. Eur Respir J 10:1008-1014, 1997.
11. Sekut L, Yarnall D, Stimpson SA, Noel LS, Bateman-Fite R, Clark RL, Brackeen MF, Menius JA, Jr., Connolly KM: Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation. Clin Exp Immunol 100:126-132, 1995.
12. Howell RE, Sickels BD, Woeppel SL: Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs. J Pharmacol Exp Ther 264:609-615, 1993.
13. Cortijo J, Bou J, Beleta J, Cardelus I, Llenas J, Morcillo E, Gristwood RW: Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. Br J Pharmacol 108:562-568, 1993.
14. Manabe H, Akuta K, Sejimo H, Kawasaki H, Nukui E, Ichimura M, Kase H, Kawakita T, Suzuki F, Kitamura S, Sato S, Ohmori K: Anti-inflammatory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor. Eur J Pharmacol 332: 97-107, 1997.
15. Foissier L, Lonchampt M, Coge F, Canet E: In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor. J Pharmacol Exp Ther 278: 1484-1490, 1996.
16. Hichami A, Boichot E, Germain N, Legrand A, Moodley I, Lagente V: Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells. Eur J Pharmacol 291:91-97, 1995.
17. Suzuki F, Kuroda T, Kawakita T, Manabe H, Kitamura S, Ohmori K, Ichimura M, Kase H, Ichikawa S: New bronchodilators. 3. Imidazo[4,5-c][1,8]naphthyridin-4(5H)-ones. J Med Chem 35:4866-4874, 1992.
18. Barsan W, Hedges J, Syverud S, Dalsey W: A hemodynamic model for anaphylactic shock. Ann Emerg Med 14:834-839, 1985.
19. Amudur M, Mead J: Mechanics of respiration in unanesthetized guinea pigs. Am J Physiol 192:364-368, 1958.
20. Denis M, Douglas J, Casby J, Stolwijk J, Bouhuys A: On-line analog computer for dynamic lung compliance and pulmonary resistance. J Appl Physiol 26:248-252, 1969.
21. Mitsuhata H, Saitoh J, Hasome N, Takeuchi H, Horiguchi Y, Shimizu R: Nitric oxide synthase inhibition is detrimental to cardiac function and promotes bronchospasm in anaphylaxis in rabbits. Shock 4:143-148, 1995.
22. Manabe H, Akuta K, Okamura K, Ohmori K: KF19514, a phosphodieterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pigs. Int Arch Allergy Immunol 114: 389-399, 1997.
23. Heaslip RJ, Buckley SK, Sickels BD, Grimes D: Bronchial vs. cardiovascular activities of selective phosphodiesterase inhibitors in the anesthetized beta -blocked dog. J Pharmacol Exp Ther 257:741-747, 1991.
24. Raeburn D, Advenier C: Isoenzyme-selective cyclic nucleotide phosphodiesterase inhibitors: effects on airways smooth muscle. Int J Biochem Cell Biol 27:29-37, 1995.
25. Shah MV, Hirshman CA: Mode of action of halothane on histamine-induced airway constriction in dogs with reactive airways. Anesthesiology 65:170-174, 1986.
26. Vettermann J, Beck KC, Lindahl SG, Brichant JF, Rehder K: Actions of enflurane, isoflurane, vecuronium, atracurium, and pancuronium on pulmonary resistance in dogs. Anesthesiology 69:688-695, 1988.
27. Lohman IC, Halonen M: The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit. Am Rev Respir Dis 147:1223-1228, 1993.
28. Kelly LJ, Undem BJ, Adams GKD: Antigen-induced contraction of guinea pig isolated pulmonary arteries and lung parenchyma. J Appl Physiol 74:1563-1569, 1993.
29. 4 are potent endothelium-dependent relaxing agents in canine splanchnic venous capacitance vessels. Circ Res 73: 395-404, 1993
30. Cooper D: Cardiac dysfunction during anaphylaxis in patients. Appl Cardiopul Pathophysiol 5:9-18, 1993.
31. Bakathir HA, Giessler J, Hirschelmann R: Rat heart anaphylaxis: influence of mediator antagonists. Gen Pharmacol 22:673-675, 1991.
32. Torphy TJ, Zhou HL, Cieslinski LB: Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J Pharmacol Exp Ther 263:1195-1205, 1992.
33. Torphy TJ, Livi GP, Balcarek JM, White JR, Chilton FH, Undem BJ: Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma. Adv Second Messenger Phosphoprotein Res 25: 289-305, 1992.